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Aim of this study: Gochnatia polymorpha ssp. ﬂoccosa (Asteraceae), popularly known as “cambará”, is
well recognized in Brazilian traditional medicine to treat the respiratory tract inﬂammatory diseases
and rheumatism. However, no scientiﬁc data have been published to support this ethnopharmacological
use. This work aimed to evaluate the anti-inﬂammatory action of its ethanol (EEGP) extract, ethyl acetate
(EA), dichloromethane (DCM), petroleum ether (PE) butanolic (BT) fractions, and the isolated compounds
bauerenyl acetate (GPC1) and 11,13-dihydrozaluzanin C (GPC2).
Materials and methods: The anti-inﬂammatory activitieswere evaluated inmice subjected to pawoedema
and carrageenan-induced air pouch inﬂammation models.
Results: The oral administration of EEGP (30, 100 and 300mg/kg), DCM (50mg/kg), BT (20mg/kg) and
GPC2 (10 and 30mg/kg), but not EP and EA fractions (both at 30mg/kg) and GPC1 (1 and 10mg/kg), sig-
niﬁcantly inhibited the pawoedema induced by carrageenan (41±13, 39±5 and 60±10% for EEGP at the
three doses, respectively; 44,47±12.8 and 70.19±11.52% for DCM and BT, respectively; and 29.52±4.8
and 31.67±5.4%, for 11,13-dihydrozaluzanin C at 10 and 30mg/kg, respectively) compared to control
group. Theoral administrationof EEGP (30, 100 and300mg/kg) inhibited the carrageenan-induced leuko-
cyte migration in the air pouch model (37.2±12.5, 62.6±5.0 and 54.3±6.8%, respectively), as well as
protein extravasation (47.9±12.5, 51.7±15.2 and 60.9±13.7%, respectively) compared to control group.
In a similar way, DCM (50mg/kg) or GPC2 (10mg/kg), but not BT (20mg/kg) given by oral route inhibited
leukocyte inﬁltration into the pouch (29.5±10.6 and 54.4±21.8%, respectively). Also DCM and GPC2
signiﬁcantly reduced the protein levels in the supernatants (52.4±15.0 and 51.83±16.9%, respectively).
Conclusion: The results suggest that EEGP, and BT and DCM fractions from G. polymorpha possess anti-
inﬂammatory activity and probably the compound 11,13-dihydrozaluzanin C was responsible, at least in
 
part, for this action.
. Introduction
Several diseases, such as cancer, diabetes, atherosclerosis
nd arthritis are often associated with inﬂammation and many
esearchers have showed that chronic inﬂammation may be
he common factor in many diseases (Medzhitov, 2008). Anti-
nﬂammatory therapies are directed towards the inhibition of
peciﬁc enzymes and/or antagonism of speciﬁc receptors and the
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translational response of proteins involved in inﬂammation. The
widely used cyclooxygenase (COX) inhibitors, anti-tumor necrosis
factor  (TNF-) (Chan and Carter, 2010) and corticosteroids are
examples of this approach that is used with the goal of blocking the
production and/or action of pro-inﬂammatory chemical mediators
(Serhan, 2008). Although corticosteroids are strong and effective
anti-inﬂammatory drugs, long-term use may require increasing
doses and cause unwanted side effects, such as hypertension,
oedema, weight gainand insulin resistance. Non-selective COX
Open access under the Elsevier OA license.inhibitors may cause gastrointestinal bleeding and kidney damage
and more selective COX-2 inhibitors increase the risk of cardio-
vascular disease. Thus, there is an urgent need for effective and
well-tolerated anti-inﬂammatory (Mukherjee et al., 2001; Sommer
and Birklein, 2010).
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Natural compounds with different mechanisms of action can
e used to treat inﬂammatory diseases (Rios et al., 2009), espe-
ially from plants being used for such purposes. A number of plants
raditionally used exhibit pharmacological properties with great
otential in therapeutic applications. One important example is
he willow tree and salicin that have been associated with sali-
ylic acid, the key precursor molecule that has contributed to the
iscovery of acetylsalicylic acid, marketed as aspirin (Mahdi et al.,
006).
The genus Gochnatia (Asteraceae) comprises 70 species, which
re found mainly in America, from Mexico to Argentine (Katinas
t al., 2008). Plants from Gochnatia genus are trees, which have
een popularly considered as medicinal (Zardini, 1984; Rodrigues
nd Carvalho, 2007). Gochnatia polymorpha (Less) Cabr. is the most
bundant species growing in Brazil, Paraguay, Uruguay, and Argen-
ine, being recognized three subspecies, polymorpha, ceanothifolia,
nd ﬂoccosa (Cabrera and Klein, 1973). It is known as “cambará”,
nd ﬂowers, leaves and trunk bark have beenused in the traditional
edicine for treating cough, bronchitis, colds, sore throat and res-
iratory diseases in general (Cabrera and Klein, 1973; Mentz and
chenkel, 1989; Schmeda-Hirschmann and Bordas, 1990; Garlet
nd Irgang, 2001; Bueno et al., 2005; Arambarri et al., 2008).
thnopharmacology studies showed that a of infusion of the bark
1–10%) of this plant is used to sore throat in Kaiowá and Guarani
ndigenous populations in the Caarapó Reserve, Mato Grosso do
ul, Brazil (Bueno et al., 2005) while the leaves and trunk bark
f G. polymorpha are used as tea and syrup in south of Brazil for
nﬂammatory diseases from respiratory system (Garlet and Irgang,
001).
Previous chemical studies addressing G. polymorpha (sub-
pecies polymorpha or unspeciﬁed) have reported the occurrence
f sesquiterpene lactones, dimeric guaianolides, bisabolenes, diter-
enes, triterpenes and coumarins (Farias et al., 1984; Bohmann
t al., 1986; Sacilotto et al., 1997; Catalan et al., 2003). The leaves
howed anti-inﬂammatory activity and ﬂavonoids and phenolic
ompounds were identiﬁed in the active extracts, but they were
ot the active compounds responsible to this property (Moreira
t al., 2000).
Screening for antimicrobial and cytotoxic activities of var-
ous parts of G. polymorpha ssp. ﬂoccosa showed that only
ichloromethane extract of trunk bark had signiﬁcant antibacte-
ial and antifungal activities. Extracts were inactive in the brine
hrimp lethality bioassay (Stefanello et al., 2006). There are no oth-
rs studies with this subspecies.
The present work reports the results of anti-inﬂammatory eval-
ation of the ethanolic extract, DCM, and others fractions and
solated compounds, namely bauerenyl acetate (GPC1) and 11,13-
ihydrozaluzanin C (GPC2) from trunk bark of G. polymorpha ssp.
occosa.
. Materials and methods
.1. Animals
The experiments were conducted using male Swiss mice
25–35g), housed under 12h light–dark cycle, controlled humid-
ty (60–80%), and temperature (22±1 ◦C) conditions. Food and
ater were freely available to the mice. The animals were accli-
atized to the experimentation room for at least 2h before testing
nd were used only once throughout the experiments. The studies
eported in thismanuscriptwere carriedout in accordancewith the
urrent guidelines for the care of laboratory animals and follow-
ng the guidelines set by the U.S. National Institute of Health and
as approved by the ethics committee for research on laboratory-
nimal use of the institution (Nbr. 336). The number of animalsarmacology 133 (2011) 1077–1084
was the minimum necessary to show consistent effects of the drug
treatments.
2.2. Plant material
Trunk bark of G. polymorpha (Less) Cabr. ssp. ﬂoccosa Cabr. was
collected in Curitiba, Paraná State, Brazil, in March 2004, and iden-
tiﬁed by Dr. Armando C. Cervi, Universidade Federal do Paraná. A
voucher specimen (UPCB 30.100) is deposited at the herbarium of
the Universidade Federal do Paraná, Brazil.
2.3. Preparation of extracts, fractions and isolation of compounds
Dried and powdered trunk bark (129g) was extracted at room
temperature with n-hexane and ethanol 95%, successively. The sol-
vents were removed under vacuum, yielding the crude extracts
in hexane (0.2%) and ethanol of G. polymorpha (EEGP, 1.8% or
2.322g). EEGP was suspended in EtOH–H2O (1:1) and partitioned
with dichloromethane (DCM), ethyl acetate (EA) and 1-butanol
(BT), successively. The organic layers were separated and the
solvents evaporated to give the respective residues (DCM 46.5%
or 1.07973g; EA 11.8% or 0.2739g; BT 25% or 0.2739g). The
DCM residue (11.8 g) was submitted to silica gel VLC eluted with
petroleum ether (PE), DCM, EA and MeOH. The fraction eluted with
DCM (2.10g) was submitted to silica gel chromatographic column
(CC) eluted with increasing amounts of EA in DCM. The fractions
were analyzed by thin-layer chromatography (TLC) using silica
gel plates developed in several solvent systems and compounds
were visualized by exposure under UV254/366 light and spraying
with 5% (v/v) sulfuric acid (H2SO4) in ethanol solution, followed
by heating on a hot plate. After this analysis, six fractions were
obtained. Fraction II (85.2mg) yielded G. polymorpha compound
1 (GPC1, 40.0mg) or bauerenyl acetate after recrystallization in
hexane. Fraction VII (1.1 g) was submitted to another silica gel CC,
eluted with increasing amounts of acetone in hexane to give 10
fractions after TLC analysis. Fraction 4 (350mg) yielded G. polymor-
pha compound 2 (GPC2) or 11,13-dihydrozaluzanin C almost pure.
An aliquot (25.0mg) was recrystallized in n-hexane, yielding pure
GPC2 (9.6mg). Nuclear magnetic resonance spectra were recorded
on a Brucker spectrometer (AC-200, operating at 200MHz for 1H
and at 50MHz for 13C), using CDCl3 (deutered chloroform) as sol-
vent and tetramethylsilane as internal reference. The yielding of
the fractions and isolated compounds were used to calculate the
doses to be used.
2.4. Materials and reagents
-Carrageenan (Cg) and dexamethasone were purchased from
Sigma Chemical Co. (St. Louis, MO). Other drugs and reagents used
were of analytical grade.
2.5. Carrageenan-induced cell migration into the pouch
Air pouch model of inﬂammation was performed as described
previously (Garcia-Ramallo et al., 2002), with some modiﬁcations.
Mice were brieﬂy anesthetized with cetamine and xylasine and
4mL of sterile air was injected subcutaneously in the back of
mice, on day 0. On day 3, a second injection of 2mL of sterile
air was performed into the preformed pouch. On day 6, ani-
mals were treated with vehicle, dexamethasone (0.5mg/kg, s.c.)
as positive control drug or EEGP (30, 100 and 300mg/kg orally),
DCM fraction (50mg/kg orally), BT fraction (20mg/kg orally),
and 11,13-dihydrozaluzanin C (10mg/kg, orally) and 1h later the
inﬂammatory response was induced by a injection of a solution of
carrageenan 0.1% (250l) directly into the pouch.
nopharmacology 133 (2011) 1077–1084 1079
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Four hours after the inﬂammatory stimulus mice were
uthanized and the pouches were washed with 2mL of phosphate-
uffered saline (PBS) containing heparin (10UI/mL). Exudateswere
ollected and total cells were counted on Neubauer chamber under
ight microscopy. Exudates were then centrifuged at 1000× g for
min at 4 ◦C and the pellet suspended in 1mL of 3% albumin
nd added to previously prepared slides. Cells were stained with
osenfeld and analyzed under light microscopy and 100 cells were
ounted.
.5.1. Plasma leakage evaluation
Supernatant obtainedafter exudates centrifugationasdescribed
bove was used to evaluate protein leakage to the inﬂamma-
ory site. Protein levels were measured in the supernatants by
radfordıˇs reaction (Bradford, 1976), using a commercially avail-
ble Bradford method (Bioagency, São Paulo, Brazil). Brieﬂy, 10l
f the samples were added to 200l of Bradfordıˇs reactant and
bsorbance was measured at 595nm. Results were interpolated to
standard curve and represented as mg/protein/100l.
.6. Carrageenan-induced paw-oedema
Different groups of mice were orally treated with EEGP (30, 100
nd 300mg/kg), DCM fraction (50mg/kg), other fractions such as
T (20mg/kg), EA and PE (both at 30mg/kg), GPC1 (1 and 10mg/kg)
r GPC2 (1, 3, 10 and 30mg/kg) or vehicle. Another group of mice
ere treated subcutaneouslywith the anti-inﬂammatorydrugdex-
methasone (0.5mg/kg). After 1h, the animals received a 50l s.c.
njection into the right hindpaw of carrageenan (300g/paw) sus-
ended in sterile 0.9% saline. The contralateral paw received only
aline and was used as control. The thickness of the paw oedema
as measured using a digital micrometer (Great, MT-045B) 1h
efore any treatment and at different time points (0.5, 1, 2, 4 and
4h) after the injection of carrageenan. Results were expressed
n m and the difference between basal and post-injection values
uantiﬁed as oedema (Kassuya et al., 2009).
.7. Determination of myeloperoxidase (MPO) activity
To investigate whether oral treatment with extract, frac-
ions and isolated compounds could affect the cellular migration
nduced by carrageenan the myeloperoxidase activity was mea-
ured into the mouse paw. For this purpose, animals were
reated with GPC2 (1–30mg/kg) or vehicle (solution with 0.1%
f Tween 80) 1h prior to carrageenan injection (300g/paw).
nimals were euthanized 4h after carrageenan injection, the
issues of the injected paws were removed and processed as
escribed before (De Young et al., 1989). For MPO activity,
he tissue was homogenized in 5% (w/v) of 80mM phosphate
uffer, pH 5.4, containing 0.5% of hexadecyltrimethylammo-
ium bromide. The homogenate was centrifuged at 12,000× g
nd 4 ◦C for 20min. Aliquots (30l) of each supernatant
ere mixed with 100l of phosphate buffer 80mM, 85l
f phosphate buffer 0.22M and 15l of 0.017% H2O2 on a
6-well plate. The reaction was triggered with 20l of 3,3,3-
etramethylbenzidine (dissolved in N,N-dimethylformamide). The
late was kept at 37 ◦C for 3min, after which the reaction
as stopped by adding 30l of sodium acetate 1.46M, pH 3.0.
he enzymatic activity was determined by measuring the opti-
al density at 630nm and was expressed as mOD per mg of
rotein..8. Statistical analysis
Data are presented as mean± S.E.M. Difference between groups
as evaluated by analyses of variance (one-way ANOVA) followedFig. 1. Structures of bauerenyl acetate (A) and 11,13-dihydrozaluzanin C (B).
by Newman–Keuls test. The number of animals per group is indi-
cated in the legends. Statistical differences were considered to be
signiﬁcant at P<0.05. Asterisks (*) denote signiﬁcant difference
compared to vehicle-treated group.
3. Results
3.1. Bio-guided isolation of compounds from G. polymorpha
trunk bark
The crude extract in ethanol of trunk bark of G. poly-
morpha ssp. ﬂoccosa (EEGP) showed anti-inﬂammatory activity,
which remained in the dichloromethane and 1-butanol frac-
tions. Chromatographic fractionation of dichloromethane fraction
yielded two major compounds, GPC1 and GPC2. Analysis
of NMR spectra and comparison with reported data led to
identiﬁcation of GPC1 as bauerenyl acetate, a pentacyclic
triterpene (Fig. 1A) previously reported in the bark of G. poly-
morpha ssp. unspeciﬁed (Farias et al., 1984). In the same
way, GPC2 was identiﬁed as sesquiterpene lactone 11,13-
dihydrozaluzanin C (Fig. 1B) (Bohlmann and Chen, 1982). This
compound is being reported for the ﬁrst time in G. polymor-
pha.
3.2. Effect of EEGP on carrageenan-induced leukocyte migration
into the pouch
The injection of carrageenan in the pouch in the sixth-day-old
promoted a plasma leakage and leukocyte migration comprised
mainly by polymorphonuclear leukocytes (Fig. 2A–C). Analysis
of variance showed signiﬁcant difference between groups on
leukocyte migration (F(5,46) = 20.76; P<0.001) and protein exu-
dation (F(5,26) = 6.713; P<0.001). Analysis of the inﬂammatory
activity of EEGP (30–300mg/kg) indicated that this extract inhib-
ited leukocyte migration (37.2±12.5%, 62.6±5.0% and 54.3±6.8%,
respectively) and plasma leakage (47.9±12.5%, 51.7±15.2% and
60.9±13.7%, respectively). Dexamethasone, used as positive con-
trol, reduced both leukocyte inﬁltration into the pouch and protein
exudation (76.7±5.5% and 63.6±12.9%, respectively) 4h after car-
rageenan injection (Fig. 2A–C).
3.3. Effect of EEGP on carrageenan-induced paw oedema
The injection of carrageenan in the paw induced an oedema
that started at 30min and peaked at 2h (Fig. 3A). Analysis of vari-
ance showed signiﬁcant difference between groups (F(4,21) = 5.387;
P<0.01). The oral treatment with EEGP signiﬁcantly inhibited
Cg-induced paw oedema formation in a dose dependent man-
ner (Fig. 3A and B), the inhibition were of 41±13%, 39±5% and
60±10% at doses of 30, 100 and 300mg/kg, respectively (Fig. 3A
and B). Moreover, our results showed that the EEGP at dose of
100mg/kg, presented its maximal inhibition 2h after its admin-
1080 R.d.R. Piornedo et al. / Journal of Ethnopharmacology 133 (2011) 1077–1084
Fig. 2. Effect of EEGPoncarrageenan-induced leukocytemigrationandplasma leakage into the air pouch.Mice (n=8–10)werepretreated1hbeforewithEEGP (30–300mg/kg,
p.o.), dexamethasone (0.5mg/kg, s.c., diluted in saline) or vehicle. Pouches were washed with PBS containing heparin. Cells were counted and plasma leakage was analyzed.
I expre
R rmed
g an–K
i
a
w
(
3
c
(
t
p
c
p
t
f
m
(
F
a
i
mn (A), number of cells that migrates to the pouches 4h after carrageenan. Results are
esults are expressed as mg of protein/ml. In (C), differential cell counting was perfo
roups were analyzed by analysis of variance (one-way ANOVA) followed by Newm
stration, as indicated by the time course analysis (Fig. 3A). In
ddition, the inhibition observed in dexamethasone-treated group
as 81.2±2.8% after 2h of the injection of carrageenan in the paw
Fig. 3A).
.4. Effect of fractions from G. polymorpha on
arrageenan-induced paw oedema
The oral treatment of the animals with DCM fraction
50mg/kg) and BT fraction (20mg/kg), but not EA or PE frac-
ion (30mg/kg, Fig. 4A) signiﬁcantly inhibited the Cg-induced
aw oedema (Fig. 4A). Analysis of variance showed signiﬁ-
ant difference between groups (F(3,17) = 61.85; P<0.0001). The
ercentage of inhibition at 120min after carrageenan injec-
ion was 44.47±12.8 and 70.19±11.52% for DCM and BT
ractions, respectively. Dexamethasone also inhibited oedema for-
ation (88.24±8.03%) in comparison to vehicle pre-treated group
Fig. 4A).
ig. 3. Effect of EEGP on carrageenan-induced paw oedema in mice. Animals received E
nd after 1h, an intraplantar injection of carrageenan (300g/paw) was performed. In (A)
s shown. In (B), bars show the effect of different doses of EEGP and dexamethasone in p
ean± SEM of 6 animals. *P<0.05, **P<0.01, ***P<0.001, compared with vehicle-treatedssed as cell 106/cavity. In (B), plasma leakage was measured by Bradford’s reaction.
. *P<0.05, **P<0.01, ***P<0.001, compared to the vehicle group. Difference between
euls test.
3.5. Effect of fractions from G. polymorpha on
carrageenan-induced leukocyte migration into the pouch
When DCM (50mg/kg), but not BT (20mg/kg), was given to
the animals, the leukocyte migration (including neutrophil and
mononuclear cells) was inhibited and the maximal inhibition
observed with DCM fraction was 29.53±10.6% when compared
to vehicle group (Fig. 4, panels B and D). However, both DCM
(50mg/kg) and BT fraction (20mg/kg) inhibited plasma leakage
with inhibition of 52.42±15.0% for DCM fraction and 58.2±11.2%
for BT fraction (Fig. 4C). Difference between groups on leuko-
cyte migration (F(4,29) = 27.69; P<0.0001) and plasma leakage
(F(4.30) = 13.08; P<0.0001) was showed by analysis of variance.3.6. Effect of 11,13-dihydrozaluzanin C and bauerenyl acetate on
carrageenan-induced paw oedema and increase of MPO activity
Pre-treatment of the animals with GPC2 (10 and 30mg/kg,
p.o.), but not with GPC1 (1 and 10mg/kg) reduced oedema forma-
EGP (30, 100 or 300mg/kg, p.o.), dexamethasone (DEX – 0.5mg/kg, s.c.) or vehicle
, the time-course of the inhibition induced by 100mg/kg EEGP and dexamethasone
aw oedema (mm) 2h after carrageenan injection. Each bar or point represents the
group.
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Fig. 4. Effect of DCM, BT, EP or EA fractions fractions on carrageenan-induced paw oedema and leukocyte migration and plasma leakage into the air pouch. Mice received
DCM (50mg/kg p.o.), BT (20mg/kg, p.o.), PE or EA (both at 30mg/kg, p.o.) dexamethasone (0.5mg/kg, s.c.) or vehicle 1h before carrageenan stimulus (n=4–6 animals per
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aroup). In (A), oedema was observed at different 120min (n=4–6 animals per gro
esults are expressed as cell 106/cavity. In (C), plasma leakage was measured by
ounting was performed. **P<0.01, ***P<0.001 compared to the vehicle group. Diffe
y Newman–Keuls test.
ion (Fig. 5A and B). No difference between GPC1 treated groups
both doses) and vehicle group was showed by analysis of variance
F(2,14) = 0.8784; P=0.4371).
Paw oedema inhibition produced by GPC2 (1–30mg/kg) was
ose dependent (Fig. 6A). Analysis of variance showed signif-
cant difference between groups (F(5,27) = 8.189; P<0.0001). At
oses of 10 and 30mg/kg, but not lower doses, GPC2 was able
o attenuate oedema formation at 120min after carrageenan
njection (29.52±4.8 and 31.67±5.4%, respectively). Dexametha-
one inhibited oedema formation (45.49±5.83%) at 120min after
nﬂammatory stimulus (Fig. 6A).
The subcutaneous injection of carrageenan (300g/paw)
ncreased MPO activity about three-fold when compared with the
awsof animals treated saline, resulting fromcarrageenan-induced
eukocyte migration to the local of insult, thereby, it is a indicative
f leukocyte presence (Fig. 6B). Analysis of variance showed sig-
ig. 5. Effect of bauerenyl acetate and 11,13-dihydrozaluzanin C on carrageenan-induc
1 and 10mg/kg, p.o.), 11,13-dihydrozaluzanin C (10mg/kg, p.o.), dexamethasone (Dex
300g/paw). In (A), the time-course of the inhibition induced by bauerenyl acetate and
cetate in paw oedema (mm) 2h after carrageenan injection. Each bar or point representn (B), number of cells that migrates to the pouch 4h after carrageenan stimulus.
ordıˇs reaction. Results are expressed as mg of protein/ml. In (D), differential cell
between groups was analyzed by analysis of variance (one-way ANOVA) followed
niﬁcant difference between groups (F(6,11) = 24.85; P<0.0001). The
GPC2 was able to inhibit signiﬁcantly (30.6±9.44, 51.27±3.38 and
54.56±2.36%) the MPO activity with dose of 3, 10 and 30mg/kg
(Fig. 6B).
3.7. Effect of 11,13-dihydrozaluzanin on carrageenan-induced
leukocyte migration into the pouch
The isolated compound GPC2 at 10mg/kg, reduced signiﬁcantly
the leukocyte migration (mainly polymorphonuclear cells) to the
cavity (54.37±21.8% (F(3,20) = 25.97; P<0.0001)) as illustrate in
Fig. 7, panels A and C. Animals which were pre-treated with GPC2
(10mg/kg), showed a decreased plasma leakage (51.83±16.9%,
(F(3,19) = 12.90; P<0.0001) Fig. 7, panel B) compared to vehicle pre-
treated.
ed paw oedema in mice. In the upper panels, animals received bauerenyl acetate
– 0.5mg/kg, s.c.) or vehicle and after 1h, an intraplantar injection of carrageenan
11,13-dihydrozaluzanin C is shown. In (B), a dose response curves for bauerenyl
s the mean± SEM of 6 animals. **P<0.01, compared with vehicle-treated group.
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Fig. 6. Effectof11,13-dihydrozaluzaninConcarrageenan-inducedpawoedema inmice. In theupperpanels, animalswere treatedwith11,13-dihydrozaluzaninC (1–30mg/kg,
p.o.), dexamethasone (DEX – 0.5mg/kg, s.c.) or vehicle and after 1h, an intraplantar injection of carrageenan (300g/paw). In (A), bars show the effect of different doses of
11,13-dihydrozaluzanin C and dexamethasone in paw oedema (mm) 2h after carrageenan injection. In (B), the inhibition induced by 11,13-dihydrozaluzanin C in increasing
of myeloperoxidase (MPO) activity induced by local injection of carrageenan. Each bar or point represents the mean± SEM of 6 animals. *P<0.05, ***P<0.001, compared with
vehicle-treated group.
Fig. 7. Effect of 11,13-dihydrozaluzanin C on carrageenan-induced leukocyte migration and plasma leakage into the air pouch. Mice (n=8–10) were pretreated 1h before
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aith 11,13-dihydrozaluzanin C (10mg/kg, p.o.), dexamethasone (0.5mg/kg, s.c., dil
ounted and plasma leakage was analyzed. In (A), number of cells that migrates to
eakage was measured by Bradfordıˇs reaction. Results are expressed as mg of prote
he vehicle group. Difference between groups were analyzed by analysis of varianc
. Discussion
The present study showed inhibitory properties of oral treat-
ent of the ethanolic extract (EEGP), DCM and BT fractions
btained from G. polymorpha, a plant popularly used against
nﬂammatory diseases in some countries, including Brazil. Fur-
hermore, the anti-inﬂammatory effect, specially inhibition of
eukocyte migration and plasma leakage, of the crude extract and
CM fraction is associated with the sesquiterpene lactone 11,13-
ihydrozaluzanin C. G. polymorpha, which has been used by the
opulation as a natural remedy to treat infectious or inﬂammatory
onditions (Mors et al., 2000). These facts lead us to investi-
ate the potential anti-inﬂammatory effect of this plant. Only the
tudy of Moreira et al. (2000) has been published to support this
thnopharmacological use of G. polymorpha. Our study extended
nd corroborated the study of Moreira et al. (2000) showing the
bility of the EEGP in inhibiting the oedema, myeloperoxidasen saline) or vehicle. Pouches were washed with PBS containing heparin. Cells were
uches 4h after carrageenan. Results are expressed as cell 106/cavity. In (B), plasma
In (C), differential cell counting was performed. *P<0.05, ***P<0.001, compared to
-way ANOVA) followed by Newman–Keuls test.
activity and leukocyte migration induced by carrageenan in the
paw and in the air pouch. The marked increase in the myeloper-
oxidase activity into the paw indicated an inﬂammatory process
induced by carrageenan, instead of only oedema, and these results
corroborated with others showing the anti-inﬂammatory efﬁcacy
induced by EEGP. We also evaluated the anti-inﬂammatory effects
of semi-puriﬁed (BT, DCM, PE, EA) fractions obtained from EEGP.
Our results demonstrated that the BT or DCM fractions, tested by
oral route, were effective in reducing the paw oedema induced by
carrageenan in mice and also inﬂammation into the pouch.
The potential anti-inﬂammatory or anti-oedematogenic prop-
erties of pharmacological substances experimentally induced in
rodents uses the digital water plethysmometer or micrometer
methodology. The bedding of plethysmometer is the water dis-
placement produced by immersion of the animal paw in the
measuring tube inducing a change in the conductance between
electrodes. Sharma et al. (2004) compared plethysmometer and
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icrometer methods to measure acute paw oedema for screening
nti-inﬂammatory activity in mice and described and suggested
hat micrometer method is more sensitive to detect the lowest
nti-inﬂammatory dose of indomethacin when compared with the
lethysmometer method (Sharma et al., 2004).
Both DCM and BT fractions inhibited oedema formation and
rotein extravasation induced by carrageenan which suggests
hat both fractions possess compounds that potentially should be
tudied as anti-inﬂammatory. However, DCM fraction showed an
nhibitory effect on leukocyte migration, an important additional
ctivity which certainly contributes to its anti-inﬂammatory activ-
ty. For this reason, we decided to focus our studies, initially, in
his fraction. Phytochemical studies showed that DCM fraction
f G. polymorpha ssp. ﬂoccosa presents as major components the
riterpene bauerenyl acetate (GPC1) and the sesquiterpene lactone
1,13-dihydrozaluzanin C (GPC2). In the present study, only the
esquiterpene lactone 11,13-dihydrozaluzanin C presented anti-
nﬂammatory activity when tested in a DCM yielding-based dose.
oreira et al. (2000) have showed that ethanolic fraction of G.
olymorpha leaves showed signiﬁcant anti-oedematogenic activ-
ty with a dose of 150mg/kg on carrageenan model in rats. The
mino acid 4-hydroxy-N-methyl-proline isolated from G. polymor-
ha showed signiﬁcant inhibition of oedemawith a dose 200mg/kg
Moreira et al., 2000) but not in equivalent doses of extract
xhibiting activities. Probably the variation in composition of G.
olymorpha according to the part of plant (leaves) and season of the
ollected species could explain previous results reporting the most
ctivity in themore polar fraction (ethyl acetate), containing caffeic
cid, chlorogenic acid, 3-O-methylquercetin, rutin and hypero-
ide (Moreira et al., 2000). Nevertheless, the anti-inﬂammatory
ffects of 11,13-dihydrozaluzanin C have never been described.
he compound 11,13-dihydrozaluzanin was able to inhibit Cg-
nduced oedema formation and decrease the MPO activity into
he injured tissue in the Cg-induced paw oedema in mice. The
PO is an enzyme present, mainly, in neutrophils and the increase
f in the MPO activity reﬂects the neutrophil migration into the
issue during inﬂammation. Thus, this is the ﬁrst study showing
hat oral administration of 11,13-dihydrozaluzanin C reduces, in
dose-dependent manner, leukocyte migration and plasma leak-
ge, suggesting that this sesquiterpene lactone is, at least in part,
esponsible for the anti-inﬂammatory effects of the G. polymor-
ha.
The pharmacological activities of some medicinal plants, espe-
ially those from the sunﬂower family Asteraceae, are attributed
o their contents of sesquiterpene lactones such as mikanolide,
elenalin, parthenolide, artemisinin, bis(isoalantodiol-B) glutarate
Valerio et al., 2007). In fact, sesquiterpene lactones may present a
ide variety of activities including in vitro antimicrobial (Pickman,
984), antiviral (Meshnick, 2002), and antitumor activities (Chen
t al., 1994). Sesquiterpene lactones also seem promising anti-
nﬂammatory drugs. It was reported that sesquiterpene lactones
nhibit inﬂammatory oedema induced by cotton pellet granu-
oma, complete Freund’s adjuvant, 4-beta-phorbol 12-myristate
3-acetate, formalin, and carrageenan (Silvan et al., 1996; Guardia
t al., 2003; Damre et al., 2003; Abil’daeva et al., 2004; Feltenstein
t al., 2004).
Sesquiterpene lactones structurally similar to 11,13-
ihydrozaluzanin C such as 8-hydroxy-11,13-dihydrozaluzanin
, zaluzanin-C and estaﬁatone, both isolated from Ainsliaea
cerifolia which has been used as antipyretic, pain-relief, and
nti-inﬂammatory in traditional herbal medicine in Korea (Shin
t al., 2005), present anti-inﬂammatory activity which may be
ue to a pharmacophoric group in the molecule. The exocyclic
-methylene--lactone was important for cytotoxic activity of
nalogs of sesquiterpene lactone helenalin (Lee et al., 1971, 1973,
977; Lee and Furukawa, 1972; Hall et al., 1978).rmacology 133 (2011) 1077–1084 1083
The study of Shin et al. (2005) showed also that zaluzanin-
C and estaﬁatone suppressed of NF-B activation by inhibition
of nuclear translocation of NF-B resulting from blockade of the
degradation of IkB, leading to suppression of the expression of
iNOS and COX-2, which display important role in inﬂammatory
signaling pathways. In addition, others analogs of 11,13-
dihydrozaluzanin C, such as 8 -hydroxy-11,13-dihydro-3-
O--d-glucozaluzanin C, 8-hydroxy-11,13-dihydrozaluzanin
C, 3-hydroxy-11,13-dihydro-8-O--d-glucozaluzanin C, 3-
hydroxy-11,13-dihydro-8-O--d-glucozaluzanin C, 3-O--d-
glucozaluzanin C showed inhibitory effects against COX-1 and
COX-2 in vitro (Wang et al., 2009).
Indeed, It has been described that several extracts from plants
rich in sesquiterpene lactones have gained considerable interest
for treating human diseases such as inﬂammation, headache and
infections (Ghantous et al., 2010). Few reviews have focused on
sesquiterpene lactones extraction, analysis and characterization
in biological systems, particularly for deﬁning their anticancer
and anti-inﬂammatory activities (Zhang et al., 2005; Gurib-Fakim,
2006).
Thus it could lead as to formulate a hypothesis that 11,13-
dihydrozaluzanin C could exert inhibitory effects in leukocyte
migration and protein exudation through inhibition of NF-B or
inhibition of COX expression. However, further studies are neces-
sary to evidence the mechanism of action of this compound.
This is the ﬁrst study showing that preparations obtained from
G. polymorpha indicating the isolated11,13-dihydrozaluzaninC, are
able to cause inﬂammatory parameters reduction in mice.
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